
Celtax 100mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Paclitaxel (100mg)
Overview Celtax 100mg Injection
Oncaspar (100mg injectable solution) is a chemotherapeutic agent indicated for the management of breast, pancreatic, and non-small cell lung cancers. Administration is exclusively via intravenous injection by a qualified healthcare provider. Dosage and frequency are determined by your physician, based on your specific condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as improper use or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for several weeks or months; discontinue use only under your physician's guidance. Common side effects include nausea, emesis, and fatigue. Potentially serious adverse events such as peripheral edema, alopecia, weight increase, and bruising are also possible. Your doctor may prescribe supplementary medication to mitigate these effects. Report any unusual bleeding or bruising, pharyngitis, oral ulcers, or pyrexia immediately. This medication may suppress hematopoiesis, increasing infection risk. Regular blood tests monitoring complete blood counts and hepatic function are mandatory. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, as well as all concurrent medications, particularly anti-infectives. Significant drug interactions are possible. This treatment is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period.
Uses of Celtax 100mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Celtax 100mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Celtax 100mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Celtax 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Celtax 100mg Injection works:
Oncaspar (100mg injection) is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Celtax 100mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Celtax 100mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Celtax 100mg Injection while breastfeeding is contraindicated due to potential infant toxicity indicated by available data.
DrivingUNSAFE
Celtax 100mg Injection can produce adverse reactions that might impair driving ability. While driving isn't necessarily prohibited between treatment cycles with Celtax 100mg Injection, its alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Celtax 100mg Injection can be used in patients with kidney impairment without altering the dosage. Nevertheless, consultation with a physician is advised for individuals with pre-existing kidney conditions.
LiverCAUTION
Patients with liver impairment should use Celtax 100mg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Celtax 100mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Celtax 100mg Injection :
NA
Facts to Know About Celtax 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Action Class | Taxanes: Antimicrotubule Agents |
